Technology | Clinical Decision Support | March 16, 2017

IBM Watson Health to Integrate MedyMatch Technology into Cognitive Imaging Offerings

MedyMatch application to help doctors identify head trauma and stroke

March 16, 2017 — MedyMatch Technology announced a collaboration with IBM  Watson Health to bring MedyMatch’s artificial intelligence (AI)-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings. In this application, the technology can help doctors identify instances of intracranial bleeding as a result of head trauma and stroke.

Initially, IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channels. Moving forward, IBM Watson Health and MedyMatch will develop interoperability between MedyMatch’s application and IBM Watson Health Imaging’s offerings.

According to the American Heart Association and American Stroke Association (AHA/ASA), stroke is the fourth leading cause of death and one of the top causes of preventable disability in the United States. Affecting 4 percent of U.S. adults, it is forecasted that by 2030, there will be approximately 3.4 million stroke victims annually in the U.S., costing the healthcare system $240 billion on an annual basis.

MedyMatch aims to bring cognitive tools into the daily workflow of an emergency department to help physicians assess patients suspected of head trauma or stroke, and rule out the presence of a bleed in the brain. The MedyMatch algorithm uses sophisticated deep learning, machine vision, patient data and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds — and does so without interrupting how a physician works.   

“The implementation of AI-based computer-aided detection and clinical decision support tools to medicine in general, and to the emergency department in particular, has the potential to increase the speed, accuracy and efficiency of patient management – with the potential to ultimately reduce diagnostic errors and improving clinical outcomes,” said Michael Lev, M.D., director of emergency radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School.  “MedyMatch is ideally positioned to leverage this technology, and their willingness to collaborate with industry partners reflects their awareness of, and sensitivity to, the complexities of patient assessment in the acute care setting.  The company’s first algorithms — CT [computed tomography] detection of intracranial bleeds — represents the confluence of physician know-how and artificial intelligence clinical support.”

MedyMatch is currently conducting a clinical trial for its intracranial bleed assessment application and is working towards a PMA (premarket approval) Class III approval by the U.S. Food and Drug Administration (FDA).

For more information: www.medymatch.com, www.ibm.com/watsonhealth

Related Content

Intelerad Medical Systems Appoints New President and CEO
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Intelerad Medical Systems announced that following the retirement of Randall Oka, its board of d
TransformativeMed Debuts Smart, Mobile-Enhanced CORE Value Suite at Cerner Conference
Technology | Electronic Medical Records (EMR) | September 25, 2018
TransformativeMed, a provider of directly embedded, smart clinical workflow solutions for electronic health records (...
Laurel Bridge Enables Healthcare Providers to Manage Image Archive Migrations and Consolidations
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Laurel Bridge Software announced improvements to their Exodus Migration and Consolidation Contro
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
Acuson Sequoia
News | Ultrasound Imaging | September 12, 2018
Siemens Healthineers announced the first global installation of its newest ultrasound system, the...
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Information Technology | September 07, 2018
Established in 1970, Sovah Health – Martinsville, Va., resides in the foothills of the beautiful Blue Ridge Mountains...